Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideREGNRegeneron Pharmaceuticals
FinDog View：Neutral
| Metric | AMGN | REGN |
|---|
| Close | 379.78 | 789.45 |
| Market Cap | $203B | $79.7B |
| 1M | −10.70% | −2.57% |
| P/E (TTM) | 23.3 | 18.5 |
| Forward P/E | 16.9 | 14.1 |
| P/E 5-Yr Percentile | 27 | 48 |
| P/S | 5.4 | 5.2 |
| P/B | 17.4 | 2.5 |
| Dividend Yield | 3.21% | 0.47% |
| Latest Quarter Revenue | $10.1B | $4.3B |
| Revenue YoY | +9.5% | +16.7% |
| Gross Margin | 72.0% | — |
| Latest Quarter EPS | 4.37 | 12.23 |
| Avg Post-Earnings Move | ±5.2% | ±1.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.60% | 4.61% |
| 90-Day Net Insider Buying | −$4.1M | −$3.4M |
AMGN · Revenue, Last 8 Quarters ($B)
REGN · Revenue, Last 8 Quarters ($B)
